nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—HTR2A—narcolepsy	0.724	1	CbGaD
Paroxetine—SLC6A2—locus ceruleus—narcolepsy	0.014	0.138	CbGeAlD
Paroxetine—HTR2A—enteric nervous system—narcolepsy	0.0128	0.126	CbGeAlD
Paroxetine—HTR2A—locus ceruleus—narcolepsy	0.00843	0.083	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—narcolepsy	0.00745	0.0734	CbGeAlD
Paroxetine—HTR2A—pons—narcolepsy	0.00486	0.0479	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—narcolepsy	0.00448	0.0441	CbGeAlD
Paroxetine—TACR1—brainstem—narcolepsy	0.00443	0.0437	CbGeAlD
Paroxetine—TACR1—forebrain—narcolepsy	0.00428	0.0422	CbGeAlD
Paroxetine—SLC6A3—brainstem—narcolepsy	0.00223	0.022	CbGeAlD
Paroxetine—CHRM2—forebrain—narcolepsy	0.00216	0.0213	CbGeAlD
Paroxetine—SLC6A3—forebrain—narcolepsy	0.00215	0.0212	CbGeAlD
Paroxetine—SLC6A4—brainstem—narcolepsy	0.00204	0.0201	CbGeAlD
Paroxetine—SLC6A4—forebrain—narcolepsy	0.00197	0.0194	CbGeAlD
Paroxetine—CHRM1—forebrain—narcolepsy	0.00197	0.0194	CbGeAlD
Paroxetine—SLC6A2—brainstem—narcolepsy	0.0018	0.0177	CbGeAlD
Paroxetine—TACR1—brain—narcolepsy	0.00178	0.0175	CbGeAlD
Paroxetine—CHRM3—forebrain—narcolepsy	0.00176	0.0173	CbGeAlD
Paroxetine—SLC6A2—forebrain—narcolepsy	0.00174	0.0171	CbGeAlD
Paroxetine—CHRM4—brain—narcolepsy	0.00167	0.0164	CbGeAlD
Paroxetine—SLC6A3—midbrain—narcolepsy	0.00142	0.014	CbGeAlD
Paroxetine—CHRM5—brain—narcolepsy	0.00131	0.0129	CbGeAlD
Paroxetine—SLC6A4—midbrain—narcolepsy	0.0013	0.0128	CbGeAlD
Paroxetine—SLC6A2—medulla oblongata—narcolepsy	0.00125	0.0124	CbGeAlD
Paroxetine—HTR2A—brainstem—narcolepsy	0.00108	0.0107	CbGeAlD
Paroxetine—HTR2A—forebrain—narcolepsy	0.00104	0.0103	CbGeAlD
Paroxetine—CYP2D6—brainstem—narcolepsy	0.000985	0.00971	CbGeAlD
Paroxetine—CYP2D6—forebrain—narcolepsy	0.000951	0.00937	CbGeAlD
Paroxetine—CHRM2—brain—narcolepsy	0.000896	0.00882	CbGeAlD
Paroxetine—SLC6A3—brain—narcolepsy	0.000893	0.0088	CbGeAlD
Paroxetine—SLC6A4—brain—narcolepsy	0.000819	0.00806	CbGeAlD
Paroxetine—CHRM1—brain—narcolepsy	0.000815	0.00803	CbGeAlD
Paroxetine—HTR2A—medulla oblongata—narcolepsy	0.000754	0.00743	CbGeAlD
Paroxetine—CHRM3—brain—narcolepsy	0.00073	0.00719	CbGeAlD
Paroxetine—SLC6A2—brain—narcolepsy	0.000721	0.0071	CbGeAlD
Paroxetine—HTR2A—midbrain—narcolepsy	0.000689	0.00679	CbGeAlD
Paroxetine—ABCB1—forebrain—narcolepsy	0.000684	0.00674	CbGeAlD
Paroxetine—CYP2C8—brain—narcolepsy	0.000592	0.00583	CbGeAlD
Paroxetine—CYP2B6—brain—narcolepsy	0.000531	0.00523	CbGeAlD
Paroxetine—ABCB1—medulla oblongata—narcolepsy	0.000494	0.00487	CbGeAlD
Paroxetine—ABCB1—midbrain—narcolepsy	0.000452	0.00445	CbGeAlD
Paroxetine—HTR2A—brain—narcolepsy	0.000433	0.00427	CbGeAlD
Paroxetine—CYP2D6—brain—narcolepsy	0.000395	0.00389	CbGeAlD
Paroxetine—ABCB1—brain—narcolepsy	0.000284	0.0028	CbGeAlD
Paroxetine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00019	0.00109	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00019	0.00109	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—PENK—narcolepsy	0.000189	0.00108	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000189	0.00108	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000188	0.00108	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000186	0.00107	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.000185	0.00106	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.000181	0.00104	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000181	0.00103	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000177	0.00101	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.000177	0.00101	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.000177	0.00101	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.000174	0.000995	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.000169	0.000969	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.000169	0.000969	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000165	0.000944	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.000165	0.000943	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.000164	0.000939	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.000163	0.000936	CbGpPWpGaD
Paroxetine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000163	0.000933	CbGpPWpGaD
Paroxetine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000163	0.000933	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000162	0.000929	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.000162	0.000927	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.000162	0.000926	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TRH—narcolepsy	0.000161	0.00092	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.000158	0.000903	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000157	0.000901	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000157	0.000901	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000156	0.000896	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000156	0.000896	CbGpPWpGaD
Paroxetine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000156	0.000894	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000156	0.000893	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000156	0.000893	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.000155	0.000887	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000154	0.000885	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000154	0.000885	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00015	0.000857	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00015	0.000857	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000149	0.000853	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000149	0.000853	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.000148	0.00085	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.000148	0.00085	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000147	0.000842	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000147	0.000842	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.000147	0.000841	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000145	0.000828	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000145	0.000828	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000144	0.000824	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.000144	0.000824	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.000144	0.000824	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.000143	0.000821	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.000143	0.000821	CbGpPWpGaD
Paroxetine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.000142	0.000814	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.000142	0.000813	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.000142	0.000813	CbGpPWpGaD
Paroxetine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.000142	0.000811	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—HRH3—narcolepsy	0.000141	0.000806	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.000141	0.000805	CbGpPWpGaD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00014	0.000799	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.000137	0.000787	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000136	0.000779	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000136	0.000779	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000135	0.000774	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000135	0.000774	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.000135	0.000772	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.000135	0.000772	CbGpPWpGaD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000134	0.000766	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.000133	0.000764	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.000133	0.000764	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.000132	0.000754	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000131	0.000752	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—HTR2A—narcolepsy	0.000131	0.000749	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.000131	0.000748	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00013	0.000746	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.000129	0.000738	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000127	0.000728	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000127	0.000726	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.000125	0.000715	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000123	0.000704	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.000122	0.0007	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.000122	0.000698	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.000121	0.000691	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00012	0.00069	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00012	0.000689	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.00012	0.000686	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.00012	0.000686	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00012	0.000685	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.000119	0.000682	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.000119	0.000682	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—HTR2A—narcolepsy	0.000119	0.00068	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.000119	0.00068	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.000119	0.00068	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.000118	0.000678	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.000118	0.000678	CbGpPWpGaD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000118	0.000676	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.000118	0.000674	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.000118	0.000674	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TAC1—narcolepsy	0.000117	0.000668	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—NPS—narcolepsy	0.000117	0.000668	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.000115	0.000661	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.000114	0.000655	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.000113	0.00065	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.000113	0.00065	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000112	0.000639	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.000111	0.000636	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.000111	0.000634	CbGpPWpGaD
Paroxetine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00011	0.000629	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00011	0.000628	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.00011	0.000628	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00011	0.000628	CbGpPWpGaD
Paroxetine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00011	0.000627	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.000109	0.000627	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000109	0.000624	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.000109	0.000622	CbGpPWpGaD
Paroxetine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000108	0.000621	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CHKB—narcolepsy	0.000108	0.000619	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.000108	0.000616	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.000106	0.000609	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.000105	0.0006	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.000102	0.000583	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	9.98e-05	0.000572	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	9.98e-05	0.000572	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—PENK—narcolepsy	9.95e-05	0.00057	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—PENK—narcolepsy	9.9e-05	0.000567	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—PENK—narcolepsy	9.86e-05	0.000565	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	9.78e-05	0.00056	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—PENK—narcolepsy	9.77e-05	0.00056	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HCRT—narcolepsy	9.73e-05	0.000557	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	9.56e-05	0.000548	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	9.56e-05	0.000548	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	9.41e-05	0.000539	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	9.38e-05	0.000537	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—TRH—narcolepsy	9.32e-05	0.000534	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HCRT—narcolepsy	9.32e-05	0.000534	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CHKB—narcolepsy	9.3e-05	0.000533	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	9.29e-05	0.000532	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	9.27e-05	0.000531	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	9.24e-05	0.000529	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	9.15e-05	0.000524	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—NPS—narcolepsy	9.07e-05	0.000519	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	9.07e-05	0.000519	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—NPS—narcolepsy	8.68e-05	0.000497	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	8.68e-05	0.000497	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PENK—narcolepsy	8.67e-05	0.000497	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TRH—narcolepsy	8.46e-05	0.000485	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TRH—narcolepsy	8.41e-05	0.000482	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TRH—narcolepsy	8.39e-05	0.00048	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TRH—narcolepsy	8.31e-05	0.000476	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PENK—narcolepsy	8.3e-05	0.000476	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.17e-05	0.000468	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	8.13e-05	0.000465	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	8.1e-05	0.000464	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.03e-05	0.00046	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.03e-05	0.00046	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	8.02e-05	0.000459	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	7.99e-05	0.000457	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	7.99e-05	0.000457	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	7.96e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	7.96e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	7.88e-05	0.000452	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	7.88e-05	0.000452	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CHKB—narcolepsy	7.88e-05	0.000451	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—P2RY11—narcolepsy	7.76e-05	0.000444	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	7.71e-05	0.000442	CbGpPWpGaD
Paroxetine—ABCB1—Allograft Rejection—TNF—narcolepsy	7.7e-05	0.000441	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	7.69e-05	0.00044	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	7.61e-05	0.000436	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HRH3—narcolepsy	7.42e-05	0.000425	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	7.38e-05	0.000423	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TRH—narcolepsy	7.37e-05	0.000422	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	7.35e-05	0.000421	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CPT1B—narcolepsy	7.35e-05	0.000421	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	7.28e-05	0.000417	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	7.17e-05	0.000411	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	7.14e-05	0.000409	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.1e-05	0.000407	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	7.07e-05	0.000405	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TRH—narcolepsy	7.06e-05	0.000404	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—HTR2A—narcolepsy	7.02e-05	0.000402	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	6.97e-05	0.000399	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CHKB—narcolepsy	6.86e-05	0.000393	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—NPS—narcolepsy	6.77e-05	0.000388	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	6.77e-05	0.000388	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	6.73e-05	0.000386	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	6.73e-05	0.000386	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	6.71e-05	0.000384	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	6.71e-05	0.000384	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	6.65e-05	0.000381	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	6.65e-05	0.000381	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HCRT—narcolepsy	6.59e-05	0.000378	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HCRT—narcolepsy	6.56e-05	0.000376	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HCRT—narcolepsy	6.54e-05	0.000374	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HCRT—narcolepsy	6.47e-05	0.000371	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CHKB—narcolepsy	6.47e-05	0.00037	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HRH3—narcolepsy	6.46e-05	0.00037	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CHKB—narcolepsy	6.41e-05	0.000367	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CPT1B—narcolepsy	6.32e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HRH3—narcolepsy	6.19e-05	0.000355	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.15e-05	0.000352	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.15e-05	0.000352	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—NPS—narcolepsy	6.11e-05	0.00035	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	6.11e-05	0.00035	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	6.09e-05	0.000349	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—NPS—narcolepsy	6.09e-05	0.000349	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	6.04e-05	0.000346	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—NPS—narcolepsy	6.04e-05	0.000346	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	6.01e-05	0.000344	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PENK—narcolepsy	5.88e-05	0.000337	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PENK—narcolepsy	5.85e-05	0.000335	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PENK—narcolepsy	5.83e-05	0.000334	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PENK—narcolepsy	5.77e-05	0.000331	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	5.75e-05	0.000329	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	5.45e-05	0.000312	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TAC1—narcolepsy	5.36e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NPS—narcolepsy	5.36e-05	0.000307	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CPT1B—narcolepsy	5.35e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	5.22e-05	0.000299	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NPS—narcolepsy	5.13e-05	0.000294	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TAC1—narcolepsy	5.13e-05	0.000294	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TRH—narcolepsy	5e-05	0.000286	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TRH—narcolepsy	4.97e-05	0.000285	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TRH—narcolepsy	4.95e-05	0.000284	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TRH—narcolepsy	4.91e-05	0.000281	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CPT1B—narcolepsy	4.66e-05	0.000267	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CPT1B—narcolepsy	4.4e-05	0.000252	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.38e-05	0.000251	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HRH3—narcolepsy	4.36e-05	0.00025	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CPT1B—narcolepsy	4.36e-05	0.00025	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HRH3—narcolepsy	4.34e-05	0.000249	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HRH3—narcolepsy	4.3e-05	0.000246	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	4.05e-05	0.000232	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	4.04e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	4e-05	0.000229	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	3.8e-05	0.000218	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	3.68e-05	0.000211	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	3.67e-05	0.00021	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TAC1—narcolepsy	3.63e-05	0.000208	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NPS—narcolepsy	3.63e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	3.63e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NPS—narcolepsy	3.61e-05	0.000207	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TAC1—narcolepsy	3.61e-05	0.000207	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NPS—narcolepsy	3.6e-05	0.000206	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TAC1—narcolepsy	3.6e-05	0.000206	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TAC1—narcolepsy	3.57e-05	0.000204	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NPS—narcolepsy	3.57e-05	0.000204	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	3.22e-05	0.000185	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	3.09e-05	0.000177	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	2.17e-05	0.000124	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	2.17e-05	0.000124	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	2.14e-05	0.000123	CbGpPWpGaD
